Clinical Trial: A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07428044) titled 'A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer' on Feb. 17.

Brief Summary: The purpose of this study is to find out how many people with HER2-amplified or HER2-mutated non-small cell lung cancer (NSCLC) experience a decrease in tumor viability when they receive trastuzumab deruxtecan before routine surgery to remove tumors.

Study Start Date: Feb. 13

Study Type: INTERVENTIONAL

Condition: Non-Small Cell Lung Cancer Non-small Cell Lung Cancer Stage II Non-Small Cell Lung Cancer Stage IIIA Non-Small Cell Lung Cancer Stage IIIB

Intervention: DRUG: Trastuzumab Deruxtecan

Trastuzumab deruxtecan (T-DXd, f...